PDS Biotechnology PDSB is set to give its latest quarterly earnings report on Thursday, 2024-11-14. Here's what investors need to know before the announcement.
Analysts estimate that PDS Biotechnology will report an earnings per share (EPS) of $-0.28.
The announcement from PDS Biotechnology is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Past Earnings Performance
Last quarter the company beat EPS by $0.11, which was followed by a 0.98% drop in the share price the next day.
Here's a look at PDS Biotechnology's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.34 | -0.37 | -0.44 | -0.45 |
| EPS Actual | -0.23 | -0.30 | -0.35 | -0.35 |
| Price Change % | -1.0% | 1.0% | 3.0% | 1.0% |
Stock Performance
Shares of PDS Biotechnology were trading at $2.96 as of November 12. Over the last 52-week period, shares are down 56.38%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for PDS Biotechnology visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
